137 related articles for article (PubMed ID: 3084060)
1. Immune complexes, serum proteins, cell-mediated immunity, and immune regulation in patients with squamous cell carcinoma of the head and neck.
Veltri RW; Rodman SM; Maxim PE; Baseler MW; Sprinkle PM
Cancer; 1986 Jun; 57(12):2295-308. PubMed ID: 3084060
[TBL] [Abstract][Full Text] [Related]
2. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
Bier J; Bitter K; Nicklisch U
J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
[TBL] [Abstract][Full Text] [Related]
3. Immune restoration with interleukin-2 in patients with squamous cell carcinoma of the head and neck.
Wanebo HJ; Jones T; Pace R; Cantrell R; Levine P
Am J Surg; 1989 Oct; 158(4):356-60. PubMed ID: 2802041
[TBL] [Abstract][Full Text] [Related]
4. Improvement of impaired leukocyte migration inhibition by thymosin in patients with head and neck squamous carcinoma.
Wolf GT; Kerney SE; Chretien PB
Am J Surg; 1980 Oct; 140(4):531-7. PubMed ID: 6999927
[TBL] [Abstract][Full Text] [Related]
5. Immune monitoring protocol for patients with carcinoma of the head and neck. Preliminary report.
Veltri RW; Sprinkle PM; Maxim PE; Theofilopoulos AN; Rodman SM; Kinney CL
Ann Otol Rhinol Laryngol; 1978; 87(5 Pt 1):692-700. PubMed ID: 309748
[TBL] [Abstract][Full Text] [Related]
6. [Immunity indices of patients with locally disseminated malignant neoplasms of the head and neck].
Bulbuk GA
Vopr Onkol; 1982; 28(4):57-9. PubMed ID: 7090271
[TBL] [Abstract][Full Text] [Related]
7. MUC1 expression and anti-MUC1 serum immune response in head and neck squamous cell carcinoma (HNSCC): a multivariate analysis.
Rabassa ME; Croce MV; Pereyra A; Segal-Eiras A
BMC Cancer; 2006 Oct; 6():253. PubMed ID: 17064405
[TBL] [Abstract][Full Text] [Related]
8. Immunologic determinants of head and neck cancer response to induction chemotherapy.
Schantz SP; Savage HE; Racz T; Liu FJ; Brown BW; Rossen RD; Hong WK
J Clin Oncol; 1989 Jul; 7(7):857-64. PubMed ID: 2472470
[TBL] [Abstract][Full Text] [Related]
9. Effects of smoking and age on serum levels of immune reactive proteins.
Wolf GT; Chretien PB; Weiss JF; Edwards BK; Spiegel HE
Otolaryngol Head Neck Surg; 1982; 90(3 Pt 1):319-26. PubMed ID: 6813806
[TBL] [Abstract][Full Text] [Related]
10. Serum immunoglobulin levels in patients with head and neck cancer (IgE, IgA, IgM, IgG).
Vinzenz K; Pavelka R; Schönthal E; Zekert F
Oncology; 1986; 43(5):316-22. PubMed ID: 3763126
[TBL] [Abstract][Full Text] [Related]
11. Immunologic aspects of human thyroid cancer. Humoral and cell-mediated immunity, and a trial of immunotherapy.
Amino N; Pysher T; Cohen EP; Degroot LJ
Cancer; 1975 Sep; 36(3):963-73. PubMed ID: 1182683
[TBL] [Abstract][Full Text] [Related]
12. The relationship of circulating IgA to cellular immunity in head and neck cancer patients.
Schantz SP; Liu FJ; Taylor D; Beddingfield N; Weber RS
Laryngoscope; 1988 Jun; 98(6 Pt 1):671-8. PubMed ID: 3259661
[TBL] [Abstract][Full Text] [Related]
13. Transference of cell mediated immunity in patients with head and neck cancer.
Vetto RM; Burger DR
Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):79-82. PubMed ID: 304143
[TBL] [Abstract][Full Text] [Related]
14. [Investigations of unspecific immune reactivity in patients with head and neck carcinoma (author's transl)].
Bier J; Nicklisch U
Arch Otorhinolaryngol; 1981; 232(2):145-63. PubMed ID: 6973965
[TBL] [Abstract][Full Text] [Related]
15. In vitro immune modulation by thymosin alpha 1 in patients with head and neck squamous cell carcinoma.
Wolf GT; Peterson KA; Lovett EJ
Head Neck Surg; 1985; 7(5):350-6. PubMed ID: 3879957
[TBL] [Abstract][Full Text] [Related]
16. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
Olkowski ZL; McLaren JR; Skeen MJ
Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
[TBL] [Abstract][Full Text] [Related]
17. Beta endorphin enhances in vitro lymphokine production in patients with squamous carcinoma of the head and neck.
Wolf GT; Peterson KA
Otolaryngol Head Neck Surg; 1986 Feb; 94(2):224-9. PubMed ID: 2938055
[TBL] [Abstract][Full Text] [Related]
18. Serum and acute phase protein modulation of the effector phase of lymphokine-activated killer cells.
Clayman GL; Taylor DL; Liu FJ; Lavedan P; Savage HE; Schantz SP
Laryngoscope; 1993 Mar; 103(3):299-307. PubMed ID: 7680086
[TBL] [Abstract][Full Text] [Related]
19. Preservation of in vitro biological functions in regional lymph node lymphocytes in squamous head and neck cancer.
Saxon A; Portaro J
Cancer Res; 1977 Apr; 37(4):1159-64. PubMed ID: 139203
[TBL] [Abstract][Full Text] [Related]
20. An immunological outcome predictive score for head and neck carcinoma patients.
Kaffenberger W; Hölzer-Müller L; Auberger T; Clasen BP; Hohlmeier G; van Beuningen D
Strahlenther Onkol; 1995 Aug; 171(8):444-53. PubMed ID: 7652667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
